share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  10/03 08:31

Moomoo AI 已提取核心信息

On September 29, 2024, 180 Life Sciences Corp. entered into an Asset Purchase Agreement with Elray Resources, Inc., acquiring source code and intellectual property for an online blockchain casino. The deal, closed on September 30, 2024, involved the issuance of 1,000,000 shares of Series B Convertible Preferred Stock and warrants to purchase 3,000,000 shares of common stock. The agreement included various representations, warranties, and covenants, along with confidentiality and indemnification requirements. Post-closing, Elray will provide support for the development of a fully operational casino for six months. 180 Life Sciences also committed to filing a proxy statement to seek shareholder approval for the issuance of the Conversion Shares and Warrant Shares. The acquisition is part of 180 Life Sciences' strategic shift towards the iGaming market, with the company expecting to meet Nasdaq's continued listing requirement of maintaining stockholders' equity of at least $2.5 million. The company also announced positive study results on a new CBD pill formulation and has strengthened its balance sheet by settling legacy liabilities and resolving litigation matters.
On September 29, 2024, 180 Life Sciences Corp. entered into an Asset Purchase Agreement with Elray Resources, Inc., acquiring source code and intellectual property for an online blockchain casino. The deal, closed on September 30, 2024, involved the issuance of 1,000,000 shares of Series B Convertible Preferred Stock and warrants to purchase 3,000,000 shares of common stock. The agreement included various representations, warranties, and covenants, along with confidentiality and indemnification requirements. Post-closing, Elray will provide support for the development of a fully operational casino for six months. 180 Life Sciences also committed to filing a proxy statement to seek shareholder approval for the issuance of the Conversion Shares and Warrant Shares. The acquisition is part of 180 Life Sciences' strategic shift towards the iGaming market, with the company expecting to meet Nasdaq's continued listing requirement of maintaining stockholders' equity of at least $2.5 million. The company also announced positive study results on a new CBD pill formulation and has strengthened its balance sheet by settling legacy liabilities and resolving litigation matters.
2024年9月29日,180生命科学公司与Elray Resources, Inc.签订了一份资产购买协议,收购了在线区块链赌场的源代码和知识产权。该交易于2024年9月30日结束,涉及发行100万股B系列可转换优先股和权证,以购买300万股普通股。协议包括各种陈述、担保和契约,以及保密和赔偿要求。交割后,Elray将为建设一个完全运营的赌场提供支持,持续六个月。180生命科学还承诺提交一份代理人声明,以寻求股东批准发行转换股和认股权股。此收购是180生命科学集团向iGaming市场战略转变的一部分,公司预计将满足纳斯达克维持至少250万美元股东权益的继续上市要求。公司还宣布了一种新CBD药丸配方的积极研究结果,并通过解决历史负债和解决诉讼事宜来加强其资产负债表。
2024年9月29日,180生命科学公司与Elray Resources, Inc.签订了一份资产购买协议,收购了在线区块链赌场的源代码和知识产权。该交易于2024年9月30日结束,涉及发行100万股B系列可转换优先股和权证,以购买300万股普通股。协议包括各种陈述、担保和契约,以及保密和赔偿要求。交割后,Elray将为建设一个完全运营的赌场提供支持,持续六个月。180生命科学还承诺提交一份代理人声明,以寻求股东批准发行转换股和认股权股。此收购是180生命科学集团向iGaming市场战略转变的一部分,公司预计将满足纳斯达克维持至少250万美元股东权益的继续上市要求。公司还宣布了一种新CBD药丸配方的积极研究结果,并通过解决历史负债和解决诉讼事宜来加强其资产负债表。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息